Filter case studies by:

Share this
  • Share on Twitter
  • Share on facebook

Panos Kanavos and Olivier Wouters

Read their case study

Resources related to the case study:

About the author and department

Personal webpages:

Panos G Kanavos: 


Olivier J Wouters: 

LSE Health and Social Care: 

Relevant research

Wouters OJ, Kanavos PG (2015). "Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform." Bulletin of the World Health Organization, 93(9): 606-613.

Cylus J, Papanicolas I, Constantinou E, Theodorou M (2013). "Moving forward: lessons for Cyprus as it implements its health insurance scheme." Health Policy, 110(1): 1-5.

Theodorou M, Charalambous C, Petrou C, Cylus J (2012). "Cyprus: health system review." Health Systems in Transition, 14(6): 1-128.

Merkur S, Mossialos E (2007). "A pricing policy towards the sourcing of cheaper drugs in Cyprus." Health Policy, 81(2): 368-375.

Golna C, Pashardes P, Allin S, Theodorou M, Mossialos E, Merkur S (2004). "Health care systems in transition: Cyprus." Copenhagen: WHO Regional Office for Europe. 117 p.

Evidence of impact

Adamou M (2016). "Questions for the Committee for Medicinal Products." [Newspaper article in Greek] Sigmalive News Cyprus, 12 January 2016. [Available from:]

Kanavos P, Wouters O (2014). "Pharmaceutical policies in Cyprus: a review of the current system and future options." Ministry of Health of the Republic of Cyprus: Nicosia. 65 p. [Available from:]

Koumasta M (2014). "WHO to the Ministry of Health: Review drug prices annually." [Newspaper article in Greek] Haravgi, 21 August 2014.

Panagi M (2014). "Drug prices based on GDP: Proposal of the World Health Organization for prices in Cyprus." [Newspaper article in Greek] Phileleftheros, 21 August 2014.

Psillides C (2014). "WHO: Cyprus needs to cut price of meds." Cyprus Mail, 21 August 2014. [Available from:]

Theodorou M (2014). "We have the most expensive drugs in the world." [Newspaper article in Greek] Politis, 21 August 2014. [Available from:]

Testimonial from the government agency in charge of implementing the national health system reform

“[The LSE] report constitutes an exemplary platform for efficiently managing the pharmaceutical sector [in Cyprus], especially in the context of a constrained budget”

- Athos Tsinontides, Acting Director General, Health Insurance Organisation, Cyprus

Read their case study